CBD Pain

Manufacturer
Global Widget, LLC
Effective date
2022-03-24
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 22:05:03

Label at a glance#

ProductCBD Pain
Active ingredientLIDOCAINE
Label structure10 sections

Indications and uses

For the temporary relief of  pain

Dosage and administration

Adults 18 years & over apply to affected area How to apply: • Use scissors to cut open the pouch • Remove clear protective liner from patch • Wash hands after applying patch • Be sure patch is dry and slowly remove from skin • Only use one patch at a time and leave the patch on for no more than 12 hours • Rotate the location of the patch, do not place in the same location two days in a row

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of  pain

Warnings

WARNINGS SECTION

FOR EXTERNAL USE ONLY

Do not use if pouch is damaged or open.Do not use:

OTC - DO NOT USE SECTION

  • On eyes or on mucous membranes
  • On wounds, damaged or irritated skin
  • If you are allergic to Lidocaine or any of the ingredients listed below

When using this product:

OTC - WHEN USING SECTION

  • Use only as directed
  • Do not bandage or cover with any type of wrap except clothing
  • Do not use with heating pad or devices, or apply external heat
  • Do not use 1 hour prior to bathing or 30 minutes after bathing

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • Localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering
  • Conditions worsen
  • Symptoms persist for more than 7 days or clear up and occur again within a few days
OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breastfeeding: Do not use this product.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults 18 years & over apply to affected area

How to apply:
• Use scissors to cut open the pouch
• Remove clear protective liner from patch
• Wash hands after applying patch
• Be sure patch is dry and slowly remove from skin
• Only use one patch at a time and leave the patch on for no more than 12 hours
• Rotate the location of the patch, do not place in the same location two days in a row

Other Information:

OTHER SAFETY INFORMATION

Reseal package after removing one patch.

Store in cool, dry place away from direct sunlight. Store 68° - 77°F (20°- 25°C). Do not allow to freeze.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Pure CBD Extract, Crossprovidone, Non-woven Backing Fabric, Polyester Film, Polyisobutylene

Questions or comments?

OTC - QUESTIONS SECTION

(800) 589-9098

Distributed by

SPL UNCLASSIFIED SECTION

Global Widget, LLC

8419 Sunstate Street, Tampa, FL 33634

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HEMP

BOMBS

CBD PAIN PATCH

LIDOCAINE 4%

labellabel

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73423-00973423-009-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
db0371d8-cb95-1d1f-e053-2a95a90ad9a3c931b59a-03af-4400-a6d0-2e6b3870ced52022-03-24WarningsExact identifier
spl id: db0371d8-cb95-1d1f-e053-2a95a90ad9a3
spl set id: c931b59a-03af-4400-a6d0-2e6b3870ced5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.